Clinical Utility of Endothelial Dysfunction in PAD

Trial Profile

Clinical Utility of Endothelial Dysfunction in PAD

Active, no longer recruiting
Phase of Trial: Phase III

Latest Information Update: 07 Aug 2015

At a glance

  • Drugs Atorvastatin (Primary) ; Ascorbic acid
  • Indications Cardiovascular disorders; Peripheral arterial disorders
  • Focus Pharmacodynamics
  • Most Recent Events

    • 06 Apr 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top